Abatacept Might Be First-Ever Treatment for Rare Immune DeficiencyAbatacept Might Be First-Ever Treatment for Rare Immune Deficiency

Some devastating aspects of common variable immune deficiency are a result of a defect in trafficking of the immune down-regulator CTLA4, which can be overcome by treatment with abatacept. Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Family Medicine/Primary Care News Source Type: news